HT-2H

Pricing inquiry (see details)

Revolutionary Holotomography opens a new era in label-free 3D live cell imaging

In the field of advanced imaging technology, Tomocube's very first generation of Holotomography stands out as a symbol of innovation. Leveraging groundbreaking 3D quantitative phase imaging technology, the HT-2H employs diffraction tomography to produce high-resolution 3D holographic images of unlabeled live cells and tissues. This innovative imaging series enables the rapid and straightforward acquisition of real-time, nanoscale images of individual cells, without the need for sample preparation.

By reconstructing a 3D distribution map of the refractive index of biological specimen from multiple 2D holograms, HT-2H provides researchers with essential insights into various cellular and subcellular organelle characteristics, such as volume, shape, cytoplasmic density, surface area, or deformability. Meanwhile, its long-term time-lapse imaging capability enables researchers to observe dynamic changes within samples over extended periods.

Additionally, the HT-2H seamlessly integrates the two complementary modalities of Holotomography and fluorescence imaging, excelling in its ability to offer long-term tracking of specific targets while minimizing unwanted stress to cells. Winner of the Microscopy Today 2019 Innovation Award, the HT-2H facilitates broader access for researchers and clinicians to quantitatively investigate cell pathophysiology and assess the effectiveness of drug interventions.